Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013037813) METHODS FOR PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2013/037813 International Application No.: PCT/EP2012/067815
Publication Date: 21.03.2013 International Filing Date: 12.09.2012
Chapter 2 Demand Filed: 11.07.2013
IPC:
G01N 33/574 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
574
for cancer
Applicants:
EUROPATH BIOSCIENCES, S.L. [ES/ES]; Provença, 392 planta baja E-08025 Barcelona, ES (AllExceptUS)
FUNDACIÓ CLINIC PER A LA RECERCA BIOMÈDICA (FCRB) [ES/ES]; Villarroel, 170 E-08036 Barcelona, ES (AllExceptUS)
DONOVAN, Michael J. [IE/ES]; ES (UsOnly)
ERILL SAGALÉS, Nadina [ES/ES]; ES (UsOnly)
COLOMER VALERO, Anna [ES/ES]; ES (UsOnly)
PUIG, Pere [ES/ES]; ES (UsOnly)
CAMPO, Elías [ES/ES]; ES (UsOnly)
COLOMO, Luis [ES/ES]; ES (UsOnly)
Inventors:
DONOVAN, Michael J.; ES
ERILL SAGALÉS, Nadina; ES
COLOMER VALERO, Anna; ES
PUIG, Pere; ES
CAMPO, Elías; ES
COLOMO, Luis; ES
Agent:
ARIAS SANZ, Juan; ABG Patentes, S.L. Avenida de Burgos, 16D Edificio Euromor E-28036 Madrid, ES
Priority Data:
11382290.212.09.2011EP
Title (EN) METHODS FOR PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA
(FR) MÉTHODES DE PRONOSTIC DU LYMPHOME DIFFUS À GRANDES CELLULES B
Abstract:
(EN) The method for prognosis of a patient suffering from diffuse large B-cell lymphoma (DLBCL) comprises determining in a sample from said patient the level of at least one biomarker selected from the group consisting of VEGF, BCL6, CD68, CD20, and combinations thereof.
(FR) La présente invention concerne une méthode de pronostic du lymphome diffus à grandes cellules B (LDGCB) chez un patient en souffrant, la méthode comprenant la détermination, dans un échantillon prélevé sur le patient, du taux d'au moins un biomarqueur choisi dans le groupe comprenant VEGF, BCL6, CD68, CD20 et leurs combinaisons.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)